Wilson Sonsini Goodrich & Rosati advised C4 Therapeutics on the transaction.C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC) announced that it has entered into an exclusive license and…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Leila Ahmed
…
This content is for Standard 1 Year members only. LoginJoin Now